The study conducted by Kawano-Dourado et al. focuses on proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis. The clinical practice guideline aims to optimize treatment outcomes and minimize adverse effects by monitoring drug levels in these patients. The research team consists of senior researchers, clinicians, methodologists, and professors. The findings and recommendations of this study are published in BMJ, providing valuable insights for healthcare professionals managing patients with these chronic conditions. The guideline emphasizes the importance of personalized medicine and regular monitoring for better patient care.
Source link
Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline
